Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.
CONCLUSIONS: The prevalence of CIPN, potential causes, risk factors, symptoms and molecular mechanisms underlying this pharmacoresistant condition are discussed.
PMID: 32394362 [PubMed - as supplied by publisher]
Source: Pharmacological Reports - Category: Drugs & Pharmacology Authors: Sałat K Tags: Pharmacol Rep Source Type: research
More News: Brain | Chemistry | Chemotherapy | Chronic Pain | Drugs & Pharmacology | Eloxatin | Neurology | Pain | Peripheral Neuropathy | Study | Velcade